Satsuma Pharmaceuticals Stock Return On Asset
Satsuma Pharmaceuticals fundamentals help investors to digest information that contributes to Satsuma Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Satsuma Stock. The fundamental analysis module provides a way to measure Satsuma Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Satsuma Pharmaceuticals stock.
Satsuma |
Satsuma Pharmaceuticals Company Return On Asset Analysis
Satsuma Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Satsuma Pharmaceuticals Return On Asset | -0.5 |
Most of Satsuma Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Satsuma Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Satsuma Pharmaceuticals has a Return On Asset of -0.4962. This is 94.33% lower than that of the Pharmaceuticals sector and 97.9% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Satsuma Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Satsuma Pharmaceuticals' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Satsuma Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Satsuma Pharmaceuticals by comparing valuation metrics of similar companies.Satsuma Pharmaceuticals is currently under evaluation in return on asset category among its peers.
Satsuma Fundamentals
| Return On Equity | -1.04 | |||
| Return On Asset | -0.5 | |||
| Current Valuation | (35.53 M) | |||
| Shares Outstanding | 33.15 M | |||
| Shares Owned By Insiders | 10.43 % | |||
| Shares Owned By Institutions | 57.90 % | |||
| Number Of Shares Shorted | 130.12 K | |||
| Price To Earning | 22.12 X | |||
| Price To Book | 0.42 X | |||
| EBITDA | (58.31 M) | |||
| Net Income | (70.06 M) | |||
| Cash And Equivalents | 68.06 M | |||
| Cash Per Share | 2.15 X | |||
| Total Debt | 205 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 9.18 X | |||
| Book Value Per Share | 1.14 X | |||
| Cash Flow From Operations | (51.52 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | (1.99) X | |||
| Price To Earnings To Growth | 4.50 X | |||
| Target Price | 2.0 | |||
| Number Of Employees | 25 | |||
| Beta | 0.1 | |||
| Market Capitalization | 36.8 M | |||
| Total Asset | 54.94 M | |||
| Retained Earnings | (211.79 M) | |||
| Working Capital | 46.69 M | |||
| Z Score | 99.83 | |||
| Net Asset | 54.94 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |